These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30915153)

  • 1. Likelihood-Ratio-Test Methods for Drug Safety Signal Detection from Multiple Clinical Datasets.
    Huang L; Zalkikar J; Tiwari R
    Comput Math Methods Med; 2019; 2019():1526290. PubMed ID: 30915153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Likelihood ratio based tests for longitudinal drug safety data.
    Huang L; Zalkikar J; Tiwari R
    Stat Med; 2014 Jun; 33(14):2408-24. PubMed ID: 24919793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of statistical approaches to postmarketing surveillance.
    Ding Y; Markatou M; Ball R
    Stat Med; 2020 Mar; 39(7):845-874. PubMed ID: 31912927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Likelihood ratio test-based method for signal detection in drug classes using FDA's AERS database.
    Huang L; Zalkikar J; Tiwari RC
    J Biopharm Stat; 2013; 23(1):178-200. PubMed ID: 23331230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended likelihood ratio test-based methods for signal detection in a drug class with application to FDA's adverse event reporting system database.
    Zhao Y; Yi M; Tiwari RC
    Stat Methods Med Res; 2018 Mar; 27(3):876-890. PubMed ID: 27142982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sources of Safety Data and Statistical Strategies for Design and Analysis: Postmarket Surveillance.
    Izem R; Sanchez-Kam M; Ma H; Zink R; Zhao Y
    Ther Innov Regul Sci; 2018 Mar; 52(2):159-169. PubMed ID: 29714520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating medical device adverse event signals using a likelihood ratio test method.
    Xu Z; Xu J; Yao Z; Huang L; Jung M; Tiwari R
    J Biopharm Stat; 2021 Jan; 31(1):37-46. PubMed ID: 32594849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial-Cluster Signal Detection in Medical Devices Using Likelihood Ratio Test Method.
    Hu T; Huang L; Xu J; Tiwari R
    Ther Innov Regul Sci; 2021 Jan; 55(1):56-64. PubMed ID: 32572773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the use of the likelihood ratio test methodology in pharmacovigilance.
    Chakraborty S; Liu A; Ball R; Markatou M
    Stat Med; 2022 Nov; 41(27):5395-5420. PubMed ID: 36177750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permutation-based variance component test in generalized linear mixed model with application to multilocus genetic association study.
    Zeng P; Zhao Y; Li H; Wang T; Chen F
    BMC Med Res Methodol; 2015 Apr; 15():37. PubMed ID: 25897803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of stratification on adverse drug reaction surveillance.
    Hopstadius J; Norén GN; Bate A; Edwards IR
    Drug Saf; 2008; 31(11):1035-48. PubMed ID: 18840023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
    Hoffman KB; Dimbil M; Tatonetti NP; Kyle RF
    Drug Saf; 2016 Jun; 39(6):561-75. PubMed ID: 26946292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An MCEM Framework for Drug Safety Signal Detection and Combination from Heterogeneous Real World Evidence.
    Xiao C; Li Y; Baytas IM; Zhou J; Wang F
    Sci Rep; 2018 Jan; 8(1):1806. PubMed ID: 29379048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A brief primer on automated signal detection.
    Hauben M
    Ann Pharmacother; 2003; 37(7-8):1117-23. PubMed ID: 12841826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zero-inflated Poisson model based likelihood ratio test for drug safety signal detection.
    Huang L; Zheng D; Zalkikar J; Tiwari R
    Stat Methods Med Res; 2017 Feb; 26(1):471-488. PubMed ID: 25189699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of statistical methods for safety signal detection: a simulation study.
    Chen M; Zhu L; Chiruvolu P; Jiang Q
    Pharm Stat; 2015; 14(1):11-9. PubMed ID: 25329607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of New Signal Detection Methods for Web Query Log Data Compared to Signal Detection Algorithms Used With FAERS.
    Colilla S; Tov EY; Zhang L; Kurzinger ML; Tcherny-Lessenot S; Penfornis C; Jen S; Gonzalez DS; Caubel P; Welsh S; Juhaeri J
    Drug Saf; 2017 May; 40(5):399-408. PubMed ID: 28155198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulation study comparing exposure matching with regression adjustment in an observational safety setting with group sequential monitoring.
    Stratton KG; Cook AJ; Jackson LA; Nelson JC
    Stat Med; 2015 Mar; 34(7):1117-33. PubMed ID: 25510526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Logistic Regression Likelihood Ratio Test Analysis for Detecting Signals of Adverse Events in Post-market Safety Surveillance.
    Nam K; Henderson NC; Rohan P; Woo EJ; Russek-Cohen E
    J Biopharm Stat; 2017; 27(6):990-1008. PubMed ID: 28346083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple self-controlled case series for large-scale longitudinal observational databases.
    Simpson SE; Madigan D; Zorych I; Schuemie MJ; Ryan PB; Suchard MA
    Biometrics; 2013 Dec; 69(4):893-902. PubMed ID: 24117144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.